Voyager Therapeutics, Inc.
VYGR
$3.26
-$0.15-4.27%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 0.19% | -37.72% | -84.18% | -589.88% | -1,296.21% |
| Total Depreciation and Amortization | -9.50% | -12.55% | -14.18% | -20.44% | -13.27% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 6.11% | 2.68% | 14.47% | 26.97% | 30.36% |
| Change in Net Operating Assets | -31.18% | 33.70% | -211.14% | 85.43% | 42.73% |
| Cash from Operations | -6.09% | -14.31% | -765.23% | -375.67% | -544.88% |
| Capital Expenditure | 61.08% | 4.22% | 26.27% | 48.43% | 53.15% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 29.34% | 112.17% | 240.18% | 244.25% | 131.86% |
| Cash from Investing | 31.79% | 117.76% | 232.24% | 224.49% | 130.47% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 445.98% | 227.64% | -99.28% | -98.90% | -98.96% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 445.98% | 227.64% | -99.28% | -98.90% | -98.96% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 74.19% | 53.78% | -261.34% | -233.22% | 80.71% |